Quikhale SF 50 mcg/250 mcg Capsule

Quikhale SF 50 mcg/250 mcg Capsule is a prescription combination medicine for asthma that contains salmeterol 50 mcg and fluticasone propionate 250 mcg in each capsule. It combines a long-acting bronchodilator (salmeterol) with an inhaled corticosteroid (fluticasone propionate) to help keep the airways open and reduce inflammation. This strength is used for ongoing control of asthma symptoms and is not a rescue treatment for sudden breathing trouble. It is manufactured by Intas Pharmaceuticals Ltd. and supplied in a strip/box of 10 capsules.

How it works: Salmeterol relaxes the muscles around the airways so breathing passages stay open for longer. Fluticasone propionate reduces swelling and irritation inside the lungs, and in this capsule form the medicine is inhaled directly into the airways for local effect.

Quikhale SF 50 mcg/250 mcg Capsule is a mid-to-higher maintenance strength compared with Quikhale SF 50 mcg/500 mcg Capsule, so a doctor may choose it when a person needs less inhaled steroid than the 500 mcg option but still needs regular controller therapy. It may be selected based on symptom control, prior inhaled steroid response, and the need to balance control with side effect risk. This strength is for people already assessed for controller treatment, not for first-time self-starting.

• Maintenance treatment of asthma
• Prevention of wheezing and shortness of breath
• Reduction of nighttime asthma symptoms
• Long-term control of airway inflammation
• Improvement of breathing in people needing combination controller therapy

• Use Quikhale SF 50 mcg/250 mcg Capsule only with the inhalation device your doctor or pharmacist recommends for this capsule type; do not swallow it whole unless specifically instructed by the product/device directions.
• Take it regularly at the same times each day, even if you feel well, because it is a controller medicine and not meant for sudden symptoms.
• Do not use it to treat an acute asthma attack; keep your rescue inhaler available for sudden wheezing or chest tightness.
• If a dose is missed, take it when remembered unless it is close to the next dose; do not double up.
• Rinse your mouth with water and spit after use to help lower the risk of oral thrush.
• Do not change the dose or stop Quikhale SF 50 mcg/250 mcg Capsule without speaking to your doctor, even if your asthma feels better.

Each capsule delivers salmeterol 50 mcg plus fluticasone propionate 250 mcg. For asthma control, Quikhale SF 50 mcg/250 mcg Capsule is usually taken regularly as prescribed, commonly twice daily, but the exact schedule depends on the patient and the inhalation device directions. Do not exceed the maximum daily dose your doctor prescribes; your clinician decides the correct dose based on your symptoms, prior treatment, and safety.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Salmeterol + Fluticasone Propionate may include:

• Hoarseness or voice changes
• Throat irritation
• Oral thrush (mouth fungal infection)
• Headache
• Cough after inhalation
• Tremor or shakiness
• Mild faster heartbeat

• Quikhale SF 50 mcg/250 mcg Capsule is not a rescue inhaler and will not stop a sudden asthma attack.
• Because this is a 250 mcg fluticasone strength, your doctor may monitor you more closely for steroid-related effects such as oral thrush and hoarseness.
• Tell your doctor if you have heart disease, high blood pressure, arrhythmias, hyperthyroidism, seizures, or diabetes.
• Use caution if you are also taking medicines that can affect heart rhythm or potassium levels.
• Do not use additional long-acting beta-agonist medicines unless your doctor specifically says so.
• Rinse and spit after each use to reduce mouth and throat side effects.
• If asthma symptoms worsen or you need your rescue inhaler more often, seek medical advice promptly.

• Other LABA inhalers or asthma medicines containing salmeterol or similar bronchodilators
• Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, or cobicistat
• Beta-blockers such as propranolol, which may reduce the bronchodilator effect
• Diuretics or other medicines that can lower potassium
• Monoamine oxidase inhibitors or tricyclic antidepressants, which may increase heart-related side effects

Store Quikhale SF 50 mcg/250 mcg Capsule in its original strip/box at room temperature, away from moisture, heat, and direct light, and keep it out of reach of children.